These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 230383)

  • 1. Effect of concanavalin A on viral infectivity, maturation and cytopathogenicity in vesicular stomatitis virus-infected cells.
    Takehara M
    Kobe J Med Sci; 1979 Dec; 25(4):205-16. PubMed ID: 230383
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell fusion in viral diseases.
    Chany C; Chany-Fournier F; Robain O
    Nature; 1987 Mar 19-25; 326(6110):250. PubMed ID: 3029598
    [No Abstract]   [Full Text] [Related]  

  • 3. Changes in ecto-5'-nucleotidase activity during early stages of vesicular stomatitis virus infection. Effects of concanavalin A.
    Daveze JL; Frappa J; Beaudry Y; Deloince R; Fontanges R
    Acta Virol; 1983 Nov; 27(6):518-22. PubMed ID: 6140838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterologous response of antiserum-treated cell clones from a persistently infected DBT cell line to mouse hepatitis virus.
    Makino S; Taguchi F; Fujiwara K; Hayami M
    Jpn J Exp Med; 1982 Dec; 52(6):297-302. PubMed ID: 6302351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of recombinant vesicular stomatitis viruses encoding mutant glycoproteins demonstrate a critical role for maintaining a high pH threshold for membrane fusion in viral fitness.
    Fredericksen BL; Whitt MA
    Virology; 1998 Jan; 240(2):349-58. PubMed ID: 9454708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Concanavalin A on cells infected with enveloped RNA viruses.
    Becht H; Rott R; Klenk HD
    J Gen Virol; 1972 Jan; 14(1):1-8. PubMed ID: 4334774
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of lyophilization on the infectivity of enveloped and non-enveloped viruses in bone tissue.
    Uhlenhaut C; Dörner T; Pauli G; Pruss A
    Biomaterials; 2005 Nov; 26(33):6558-64. PubMed ID: 15946737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vesicular stomatitis virus infection enhances invasiveness of Salmonella typhimurium.
    Bukholm G; Bjørnland K; Ellekjaer H; Berdal BP; Degré M
    APMIS; 1988 May; 96(5):400-6. PubMed ID: 2837253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further studies on the activation of hamster lymphocytes by concanavalin A.
    Tevethia SS; Singh SB
    Fed Proc; 1978 May; 37(7):2037-8. PubMed ID: 205439
    [No Abstract]   [Full Text] [Related]  

  • 10. Morphological and biochemical characterization of vesicular stomatitis virus with low infectivity released from interferon treated cells.
    Maheshwari RK; Friedman RM
    Uttar Pradesh State Dent J; 1980 Jul; 11(3):95-110. PubMed ID: 6159713
    [No Abstract]   [Full Text] [Related]  

  • 11. Recombinant vesicular stomatitis virus expressing respiratory syncytial virus (RSV) glycoproteins: RSV fusion protein can mediate infection and cell fusion.
    Kahn JS; Schnell MJ; Buonocore L; Rose JK
    Virology; 1999 Feb; 254(1):81-91. PubMed ID: 9927576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection of the central nervous system produced by R1 vesicular stomatitis virus.
    Greenstein JI; Baron-Van Evercooren AG; Lazzarini RA; McFarland HF
    Lab Invest; 1981 Jun; 44(6):487-95. PubMed ID: 6262567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vesicular stomatitis antigens recognized by cytotoxic cells: analysis with defective interfering particles and reconstituted membrane vesicles.
    Ciavarra RP; Kang CY; Forman J
    J Immunol; 1980 Jul; 125(1):336-43. PubMed ID: 6247397
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiviral activities of silver sulfadiazine in ocular infection.
    Tokumaru T; Shimizu Y; Fox CL
    Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):151-8. PubMed ID: 4368031
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of interferon on calcium.
    Singh VK; Maheshwari RK; Krishna G; Friedman RM
    Prog Clin Biol Res; 1985; 202():351-6. PubMed ID: 2421314
    [No Abstract]   [Full Text] [Related]  

  • 16. Inactivation of vesicular stomatitis virus through inhibition of membrane fusion by chemical modification of the viral glycoprotein.
    Stauffer F; De Miranda J; Schechter MC; Carneiro FA; Salgado LT; Machado GF; Da Poian AT
    Antiviral Res; 2007 Jan; 73(1):31-9. PubMed ID: 16934341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell cycle requisite for vesicular stomatitis virus replication in T lymphocytes activated with concanavalin A.
    Fujisawa H; Kumazawa Y; Ohtani A; Nishimura C
    J Clin Lab Immunol; 1984 Jan; 13(1):41-6. PubMed ID: 6325697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The biological properties and morphology of the vesicular stomatitis virus].
    Varov VN; Gaĭdamovich SIa; Klimenko SM
    Veterinariia; 1966 Jul; 43(7):17-21. PubMed ID: 4295397
    [No Abstract]   [Full Text] [Related]  

  • 19. E. coli adherence to CER cells infected by vesicular stomatitis virus.
    Chiarini F; Seganti L; Superti F; Girmenia C; Orsi N
    Boll Ist Sieroter Milan; 1985; 64(1):6-11. PubMed ID: 2988586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promotion of vesicular stomatitis virus nucleocapsid protein production by arthopod saliva.
    Kocáková P; Hajnická V; Slovák M; Nuttall PA; Fuchsberger N
    Acta Virol; 1999 Aug; 43(4):251-4. PubMed ID: 10749371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.